Wird geladen...
Establishing medical plausibility in the context of orphan medicines designation in the European Union
In the European Union, sponsors have the responsibility to demonstrate the “intention to diagnose, prevent or treat” a serious and rare condition before the Committee of Orphan Medicinal Products (COMP), for a medicinal product to meet the criteria for Orphan Designation. This requirement is commonl...
Gespeichert in:
| Veröffentlicht in: | Orphanet J Rare Dis |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4264401/ https://ncbi.nlm.nih.gov/pubmed/25475155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-014-0175-8 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|